Bought at 40.25, nibbled again at 35, loaded the boat under 30. Now I sit and wait. I've rounded out my position... Avg cost basis is now a shade under $35. Going to hold through the release of the next clinical trial results early this summer. If it maintains the course from the last results this stock will blow through 45 and head back towards the $60 mark.
Could see a natural pull back towards 33-35 between now and then, but nothing to be alarmed about
News 
Market Data 
Discover 
